LGC Diagnostics and Genomics aligns all quality control offerings under SeraCare brand

London, united kingdom (27 Apr 2026) - LGC announced today a recategorisation of its Diagnostics and Genomics business arm, bringing together existing brands, products, services and areas of scientific knowledge under four simplified pillars.

SeraCare Clinical Diagnostics houses the company's quality controls, calibration verification, reference materials, panels, external quality assessment (EQA) and proficiency testing (PT) services.

Rapid Genomics Genotyping Solutions enables mission-critical DNA extraction, genotyping and next generation sequencing (NGS) products and services that generate actionable data for commercial breeding programmes.

Biosearch Technologies Oligo-Synthesis offers tailored oligo synthesis, nucleic acid chemistry and components that deliver integrated solutions from feasibility through early development to commercialisation.

Lucigen Reagent Components provides reliable, flexible and high-quality antigens, antibodies, virus-like particles, enzymes, competent cells and biological materials fuelling diagnostic and therapeutic workflows.

The recategorisation comes as part of a commitment to customer-focused scientific excellence, providing laboratories and researchers with a simple framework to acquire the trusted life science solutions they need quickly, whilst enabling the exploration of adjacent diagnostic and genomic innovations.

Media Contact:

Heather Taylor

Director of Global Marketing LGC Diagnostics & Genomics

[email protected]

About LGC

LGC is a global leader in life sciences, diagnostics, and analytical solutions. The company partners with customers to address some of the world's most pressing challenges. Every day, its science helps to diagnose disease, treat illness, feed a growing population, and protect public health. LGC provides the components, standards, and services that underpin scientific discovery, enable better health outcomes, and safeguard the integrity of food, water, medicines, and the environment.

With operations in 14 countries and a heritage of more than 180 years, LGC's products and services are integral to public health and global sustainability. From supporting the accuracy of medical test results to verifying the safety of baby food, to helping scientists develop the next generation of medicines, LGC's solutions are trusted by customers in over 170 countries. Together with our customers, we are shaping a healthier, safer, and more sustainable world.

For more information, please visit lgcgroup.com.

About LGC Diagnostics & Genomics

With over 1,500 brilliant employees, 17,000+ products, and 11 production sites worldwide, LGC Diagnostics & Genomics is a highly trusted partner of the life sciences community. The business drives scientific progress by making trusted life science solutions simple and more innovative. Its four integral product pillars are Genotyping Solutions, Quality Measurement Tools, Oligo/Nucleic Acid Chemistry, and Reagent Components. This newly established organisation of the business helps researchers and laboratories quickly find, compare, and acquire what they need, whilst exploring adjacent diagnostic and genomics solutions.